Doral and cheyne-stokes respiration Patient Reports February 13, 2012

Doral Side Effects Report #4913506-3
Doral side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2006. Male patient, 81 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: bradykinesia, cheyne-stokes respiration, depressed level of consciousness, fall , hepatic congestion, hypometabolism, nasopharyngitis. Doral dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, ACETYLSALICYLIC ACID SRT, SELBEX, ARICEPT, EUGLUCON, NICERGOLINE. Patient was hospitalized and became disabled. Patient recovered.